» Articles » PMID: 1999069

Comparison of Liver Histology with Ultrasonography in Assessing Diffuse Parenchymal Liver Disease

Overview
Journal Clin Radiol
Specialty Radiology
Date 1991 Jan 1
PMID 1999069
Citations 143
Authors
Affiliations
Soon will be listed here.
Abstract

To establish the accuracy of ultrasonography in assessing diffuse parenchymal liver disease we performed a prospective comparative study with histology in 50 patients with a wide range of liver disease. Liver biopsy was performed within 24 h of the ultrasound examination and ultrasonography was performed by a single operator who was unaware of clinical details of the patients. Histology was reviewed blind and the degree of steatosis graded mild, moderate or severe while increased portal fibrous tissue was graded mild, moderate or established cirrhosis. Thirty-six patients had steatosis and 31 patients had increased fibrous tissue on histology. Ultrasonography correctly identified steatosis in 32/36 (89%) patients including all patients with the severe grade. Increased fibrous tissue was correctly identified in 24/31 (77%) with a sensitivity of 100% in patients with moderate fibrosis and established cirrhosis. Specificity was 93% for steatosis and 89% for increased fibrous tissue. These results show that ultrasonography can provide a non-invasive prediction of liver histology which in moderate and severe steatosis and advanced fibrosis can be both highly sensitive and specific.

Citing Articles

Association of fatty liver with serum gamma-glutamyltransferase and uric acid in obese children in a tertiary care centre.

Maduri V, Eresha J, Dulani S, Pujitha W BMC Pediatr. 2025; 25(1):144.

PMID: 40011867 PMC: 11863752. DOI: 10.1186/s12887-025-05484-0.


BMI gain and dietary characteristics are risk factors of MASLD in non-obese individuals.

Taniguchi H, Ueda M, Kobayashi Y, Shima T Sci Rep. 2025; 15(1):2606.

PMID: 39838114 PMC: 11751101. DOI: 10.1038/s41598-025-86424-x.


Artificial Intelligence and Image Analysis-Assisted Diagnosis for Fibrosis Stage of Metabolic Dysfunction-Associated Steatotic Liver Disease Using Ultrasonography: A Pilot Study.

Fujii I, Matsumoto N, Ogawa M, Konishi A, Kaneko M, Watanabe Y Diagnostics (Basel). 2024; 14(22).

PMID: 39594250 PMC: 11593288. DOI: 10.3390/diagnostics14222585.


Correlation between non-alcoholic fatty liver disease and metabolic parameters in persons with newly diagnosed type 2 diabetes mellitus.

Mukherjee S, Mukherjee S, Kwok C, Phillips A World J Hepatol. 2024; 16(8):1120-1130.

PMID: 39221103 PMC: 11362911. DOI: 10.4254/wjh.v16.i8.1120.


An observational cohort study to investigate the impact of dolutegravir in pregnancy and its obesogenic effects on the metabolic health of women living with HIV and their children: Study protocol.

Abrams E, Jao J, Madlala H, Zerbe A, Catalano P, Gerschenson M PLoS One. 2024; 19(8):e0307296.

PMID: 39159183 PMC: 11332920. DOI: 10.1371/journal.pone.0307296.